Cetero Research

 

Today's Research for Tomorrow's Healthcare
 
 
+
+
+
 +
+
 
   
     
 
Complete Validated Assays
Available assay list  
Method development and validation  
LC/MS/MS  
Immunochemistry  




  Compound Matrix Sensitivity Methodology
Nabumetone Metabolite Plasma 0.500 µg/mL LC/MS/MS
Nadolol Plasma 1.00 ng/mL LC/MS/MS
Nalmefene Plasma 2.50 ng/mL HPLC
Naloxone (Low Range) Plasma 2.00 pg/mL LC/MS/MS
Naloxone (Total) Plasma 50.0 pg/mL LC/MS/MS
Naltrexone Plasma 5.00 - 4000 pg/mL LC/MS/MS
Naproxen Plasma 1.00 µg/mL LC/MS/MS
Naratriptan Plasma 0.075 ng/mL LC/MS/MS
Nateglinide Plasma 0.0500 µg/mL LC/MS/MS
Nevirapine Plasma 5.00 ng/mL LC/MS/MS
Niacin / Nicotinuric Acid Plasma 20.0 / 20.0 ng/mL LC/MS/MS
Nicardipine Plasma 2.00 ng/mL HPLC
Nicotine Plasma 0.500 ng/mL LC/MS/MS
Nicotine Gum 100 µg/mL LC/MS/MS
Nisoldipine Plasma 50.0 pg/mL LC/MS/MS
Nitrofurantoin Urine 1.00 µg/mL HPLC
Nitrofurantoin Plasma 5.00 ng/mL LC/MS/MS
Nizatidine / Desmethylnizatidine Plasma 50.0 / 10.0 ng/mL HPLC
Nortriptyline / 10-hydroxy-Nortriptyline Plasma 1.00 ng/mL HPLC


 
 
 
|
|
|
|
|
|
 
Copyright © 2009 CRS Management. All rights reserved.
 
Developed by Web Interactive Technologies Baltimore Web Design